Skip to main content
OpenTrials
Completed

NCT Number: NCT05687396

Virtual Reality in COPD Exacerbation

In addition to conventional pulmonary rehabilitation, virtual reality will be applied during the hospitalization period of individuals hospitalized for COPD exacerbation. It is aimed to get more efficiency from the interventions in this short time.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Exacerbation Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Pulmonary Rehabilitation Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pamukkale University

Denizli, Pamukkale, 20000, Turkey (Türkiye)

About this study

Subjects with COPD exacerbation will be divided two groups. Group-1 will exercise with a bicycle ergometer until fatigue in addition to pulmonary rehabilitation. Group-2 will do the same exercises. Subjects in Group-2 will use virtual reality simulation, which is designed as cycling in the forest while cycling. Treatment will continue until discharge. CAT score, mMRC dyspnea score, hospital anxiety and depression score and London chest daily living activity score will be examined before and after treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals who are in COPD exacerbation period, FEV1 <70%, GOLD 2-3 spirometric stage, Hodkinson mental test score > 6 and who want to participate in the study voluntarily will be included in the study.

Exclusion criteria

  • If there is respiratory disease considered more significant than COPD (bronchiectasis, lung cancer requiring active therapy, or asthma), Heart failure New York Heart Association (NYHA) stage 3-4, Significant hemoptysis, surgical or non-surgical lung volume in the past 6 months Individuals with reduction procedures, Lung transplantation or pneumonectomy surgery in the last 6 months, pulmonary embolism or pulmonary edema, acute myocardial infarction, acute heart failure, vertigo, epilepsy and visual impairment will be excluded from the study.

Treatment and study plan

Virtual reality

Device

virtual reality designed as cycling in the forest

Conventional pulmonary rehabilitation

Other

pulmonary rehabilitation

Primary outcomes

  1. 1 minute sit and stand test

    Time frame: 5 minutes

    performance

  2. Chronic Obstructive Pulmonary Disease Assessment Test

    Time frame: 3-7 days

    The test assessts COPD symptoms, higher scores mean bad stiation

  3. London chest activity of daily living

    Time frame: 3-7 days

    The test assessts dyspnea that occurs during daily living activities. The total score can range from 0 to 75 points, with higher values translating to greater limitation in activities of daily living.

  4. Hospital anxiety and depression scale

    Time frame: 3-7 days

    The test has 2 subparameter as anxiety and depression. Each question in the test contains 4 options expressing frequency on a scale 0 to 3. Higher scores mean bad stiation for each parameter.

  5. Modified Medical Research Council

    Time frame: 3-7 days

    The test has 5 options thas describe dyspnea. Higher scores mean higher dyspnea.

Sponsors and collaborators

Lead sponsor

Pamukkale University

Other

Registry information

Official study title

Virtual Reality in Chronic Obstructive Pulmonary Disease: Randomized Contolled Trial

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Jan 18, 2023
Registry last updated
Sep 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.